Gut hormones have therapeutic potential in the prevention and treatment obesity and type 2 diabetes (T2D). Milk protein and calcium can each potentiate gut hormones following meal ingestion in humans. However, these nutrients may interact synergistically (and with other minerals in milk) such that specific co-ingestion of these nutrients is required to obtain the full therapeutic potential for metabolism and energy balance. This proposal is to perform a pilot study on the effect of co-ingesting Capolac® plus protein on circulating gut hormone responses.
Participants will be asked to arrive to the laboratory between 08:00 and 10:00 am after not eating for between 8-14 hours i.e. in a fasted state (water intake is permitted and encouraged). Participants will then be given one of three test drinks: 1) calcium citrate (1000 mg); 2) milk mineral supplement (equating to 1000 mg calcium); or 3) milk mineral supplement (equating to 1000 mg calcium) plus whey protein hydrolysate (50 g). Each of these drinks will also contain 500 mL of water and artificial sweetener (80 mg sucralose). Blood samples will be taken before, and at 15, 30, 45, 60, 90 and 120 minutes after ingestion of the test drink to determine the concentrations of gut hormones (GIP, GLP-1 and PYY) circulating in the bloodstream. We will also ask participants to complete an appetite questionnaire at baseline and every 30 minutes after ingestion of the test drink to assess their appetite sensations. After the 120-minute time point, we will remove the cannula and the trial day will be complete.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
20
1000 mg calcium as calcium citrate
Milk Minerals containing 1000 mg calcium
50 g whey protein hydrolysate
University of Bath
Bath, United Kingdom
Postprandial plasma GLP-1 area under the curve (mmol/L x 120 min).
Plasma glucagon-like peptide-1 (GLP-1) concentrations
Time frame: 120 min
Postprandial plasma GIP area under the curve (mmol/L x 120 min)
Plasma glucose-dependent insulinotropic peptide (GIP) concentrations
Time frame: 120 min
Postprandial plasma PYY area under the curve (mmol/L x 120 min)
Plasma peptide tyrosine tyrosine (PYY) concentrations.
Time frame: 120 min
Subjective ratings of appetite (au)
Visual analogue scales of appetite ratings
Time frame: 120 min
Energy metabolism (carbohydrate and fat oxidation)
Carbohydrate and fat oxidation (g/h) measured via indirect calorimetry
Time frame: 120 min
Postprandial plasma glucose
Plasma glucose concentrations (mmol/L).
Time frame: 120 min
Blood pressure
Systolic and diastolic blood pressure
Time frame: 120 min
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.